Ekta Khurana

Ekta Khurana

Cornell University

H-index: 42

North America-United States

About Ekta Khurana

Ekta Khurana, With an exceptional h-index of 42 and a recent h-index of 35 (since 2020), a distinguished researcher at Cornell University,

His recent articles reflect a diverse array of research interests and contributions to the field:

2231O Pan-cancer assessment of the impact of intronic variants on cancer development and progression

Recapitulation of patient-specific 3D chromatin conformation using machine learning

Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing

ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer

Discovery of novel therapeutic targets using 3D chromatin conformation and patient-specific gene regulatory networks

Abstract NG10: Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets

Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

Author Correction: Pan-cancer analysis of whole genomes

Ekta Khurana Information

University

Position

Weill Cornell Medical College, Yale University, University of Pennsylvania, Indian Institute of

Citations(all)

46946

Citations(since 2020)

19604

Cited By

37710

hIndex(all)

42

hIndex(since 2020)

35

i10Index(all)

59

i10Index(since 2020)

51

Email

University Profile Page

Google Scholar

Top articles of Ekta Khurana

2231O Pan-cancer assessment of the impact of intronic variants on cancer development and progression

Annals of Oncology

2023/10/1

Recapitulation of patient-specific 3D chromatin conformation using machine learning

Cell reports methods

2023/9/25

Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing

Nature genetics

2023/6

ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer

Science Advances

2023/4/5

Discovery of novel therapeutic targets using 3D chromatin conformation and patient-specific gene regulatory networks

Cancer Research

2023/4/4

Abstract NG10: Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets

Cancer Research

2023/4/4

Author Correction: Pan-cancer analysis of whole genomes

Nature

2023/2/16

Author Correction: Patterns of somatic structural variation in human cancer genomes

Nature

2023/2/16

Patterns of somatic structural variation in human cancer genomes (vol 578, pg 112, 2020)

Nature

2020/2/6

Modeling tissue-specific breakpoint proximity of structural variations from whole-genomes to identify cancer drivers

Nature Communications

2022/9/26

Ekta Khurana
Ekta Khurana

H-Index: 30

Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert microenvironment and is sensitized by immunogenic viruses

The Journal of Clinical Investigation

2022/9/1

Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets

Science

2022/5/27

Discovery of novel therapeutic targets in cancer using patient-specific gene regulatory networks

2022

Systems biology analysis of human genomes points to key pathways conferring spina bifida risk

Proceedings of the National Academy of Sciences

2021/12/21

Developmental chromatin programs determine oncogenic competence in melanoma

Science

2021/9/3

Patient-specific enhancer-gene networks for hundreds of primary cancer samples

Cancer Research

2021/7/1

See List of Professors in Ekta Khurana University(Cornell University)